VMC
33
3
HRB
37
2
SO
55
13
CA
16
-6
CHRW
57
-3
TRV
42
2
GT
41
-2
GIS
34
2
JCI
45
4
BK
63
2
SEE
42
-4
PCG
58
-8
COF
47
-2
NAVI
35
-5
VZ
27
3
BSX
73
4
BAC
56
2
PWR
54
-3
DLTR
44
-6
DUK
60
5
VMC
33
3
HRB
37
2
SO
55
13
CA
16
-6
CHRW
57
-3
TRV
42
2
GT
41
-2
GIS
34
2
JCI
45
4
BK
63
2
SEE
42
-4
PCG
58
-8
COF
47
-2
NAVI
35
-5
VZ
27
3
BSX
73
4
BAC
56
2
PWR
54
-3
DLTR
44
-6
DUK
60
5
Financhill
Back

Columbia Research Enhanced Core ETF Vs. Janux Therapeutics Industry Stock Comparison

Buy
53

RECS
Columbia Research Enhanced Core ETF

Last Price:
$34.90
Seasonality Move:
-0.34%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
53
Columbia Research Enhanced Core ETF (RECS) is a Buy

Is Columbia Research Enhanced Core ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Core ETF [RECS] share price is $34.92. The Score for RECS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • RECS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RECS Stock Price Chart

What is Columbia Research Enhanced Core ETF's stock price today?

  • The Columbia Research Enhanced Core ETF share price today is $34.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RECS is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

RECS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.67 Sell
Chaikin Money Flow: 579808 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.85 - 36.19) Sell
Bollinger Bands (100): (33.32 - 35.6) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

RECS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.89 Buy
20-day SMA: 35.32 Sell
50-day SMA: 35.36 Sell
200-day SMA: 32.96 Buy
8-day EMA: 34.98 Sell
20-day EMA: 35.19 Sell
50-day EMA: 35.13 Sell
200-day EMA: 32.98 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Columbia Research Enhanced Core ETF Earnings Growth & RECS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Columbia Research Enhanced Core ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):